Bavarian Nordic A/S announced the appointment of Henrik Juuel to the position of Executive Vice President and Chief Financial Officer. Mr. Juuel is currently the CFO of Orexo AB, a fully integrated specialty pharmaceutical company listed on the asdaq Stockholm exchange, a role he has held since 2013. He plans to join avarian Nordic in the fourth quarter of 2018.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
180 DKK | +1.32% | +0.70% | +1.44% |
05-21 | Bavarian Nordic’s Medical Chief to Step Down by May-end | MT |
05-08 | Transcript : Bavarian Nordic A/S, Q1 2024 Earnings Call, May 08, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.44% | 2.04B | |
+38.51% | 727B | |
+33.05% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.09% | 205B | |
-5.77% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- BAVA Stock
- News Bavarian Nordic A/S
- Bavarian Nordic Appoints Henrik Juuel as Chief Financial Officer and Executive Vice President